ConductScience.org, home

Paper37101261

Therapeutic potential of bacteriophage endolysins for infections caused by Gram-positive bacteria.

Liu H and 5 others. J Biomed Sci, 2023. Cited by 93 papers, by iCite.

Cite this record

ConductScience Library. Therapeutic potential of bacteriophage endolysins for infections caused by Gram-positive bacteria. Papers, record 37101261. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37101261

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Therapeutic potential of bacteriophage endolysins for infections caused by Gram-positive bacteria.
PubMed
Journal
J Biomed Sci
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
93
iCite
Relative citation ratio, by iCite
14.5
iCite
Revised in PubMed
2026-01-27
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Liu HHe
2Hu ZZhen
3Li MMengyang
4Yang YYi
5Lu SShuguang
6Rao XXiancai

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BacteriophagesMajor topic
Methicillin-Resistant Staphylococcus aureusMajor topic
Bacterial InfectionsMajor topic
Humans
Bacteria
Gram-Positive Bacteria
Anti-Bacterial Agents
Endopeptidases

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
31871251National Natural Science Foundation of ChinaPubMed

Source PubMed

Download CSV of grants

References168

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121048011LysGH15, a novel bacteriophage lysin, protects a murine bacteremia model efficiently against lethal methicillin-resistant Staphylococcus aureus infection.J Clin Microbiol2011https://conductscience.org/library/papers/21048011PubMed
212657053Functional regulation of the Listeria monocytogenes bacteriophage A118 holin by an intragenic inhibitor lacking the first transmembrane domain.Mol Microbiol2003https://conductscience.org/library/papers/12657053PubMed
312499217Synergistic lethal effect of a combination of phage lytic enzymes with different activities on penicillin-sensitive and -resistant Streptococcus pneumoniae strains.Antimicrob Agents Chemother2003https://conductscience.org/library/papers/12499217PubMed
422439788Antistaphylococcal activity of bacteriophage derived chimeric protein P128.BMC Microbiol2012https://conductscience.org/library/papers/22439788PubMed
525733585A novel chimeric phage lysin with high in vitro and in vivo bactericidal activity against Streptococcus pneumoniae.J Antimicrob Chemother2015https://conductscience.org/library/papers/25733585PubMed
618471063Phage lytic enzyme Cpl-1 for antibacterial therapy in experimental pneumococcal meningitis.J Infect Dis2008https://conductscience.org/library/papers/18471063PubMed
721535426Domain shuffling and module engineering of Listeria phage endolysins for enhanced lytic activity and binding affinity.Microb Biotechnol2011https://conductscience.org/library/papers/21535426PubMed
816565432Bacteriophage endolysins as a novel class of antibacterial agents.Exp Biol Med (Maywood)2006https://conductscience.org/library/papers/16565432PubMed
917827138
In vitro interactions of LytA, the major pneumococcal autolysin, with two bacteriophage lytic enzymes (Cpl-1 and Pal), cefotaxime and moxifloxacin against antibiotic-susceptible and -resistant Streptococcus pneumoniae strains.
J Antimicrob Chemother2007https://conductscience.org/library/papers/17827138PubMed
1014613958Phage lytic enzymes as therapy for antibiotic-resistant Streptococcus pneumoniae infection in a murine sepsis model.J Antimicrob Chemother2003https://conductscience.org/library/papers/14613958PubMed
1117186236Mutagenesis of a bacteriophage lytic enzyme PlyGBS significantly increases its antibacterial activity against group B streptococci.Appl Microbiol Biotechnol2007https://conductscience.org/library/papers/17186236PubMed
1230642930ClyJ Is a Novel Pneumococcal Chimeric Lysin with a Cysteine- and Histidine-Dependent Amidohydrolase/Peptidase Catalytic Domain.Antimicrob Agents Chemother2019https://conductscience.org/library/papers/30642930PubMed
1327516758PL3 Amidase, a Tailor-made Lysin Constructed by Domain Shuffling with Potent Killing Activity against Pneumococci and Related Species.Front Microbiol2016https://conductscience.org/library/papers/27516758PubMed
1432291298Targeting Hidden Pathogens: Cell-Penetrating Enzybiotics Eradicate Intracellular Drug-Resistant Staphylococcus aureus.mBio2020https://conductscience.org/library/papers/32291298PubMed
1515231813Identification of a broadly active phage lytic enzyme with lethal activity against antibiotic-resistant Enterococcus faecalis and Enterococcus faecium.J Bacteriol2004https://conductscience.org/library/papers/15231813PubMed
1630889831Phage Endolysins as Potential Antimicrobials against Multidrug Resistant Vibrio alginolyticus and Vibrio parahaemolyticus: Current Status of Research and Challenges Ahead.Microorganisms2019https://conductscience.org/library/papers/30889831PubMed
1727341401Pharmacokinetics of the phage endolysin-based candidate drug SAL200 in monkeys and its appropriate intravenous dosing period.Clin Exp Pharmacol Physiol2016https://conductscience.org/library/papers/27341401PubMed
1828860505Endolysin LysEF-P10 shows potential as an alternative treatment strategy for multidrug-resistant Enterococcus faecalis infections.Sci Rep2017https://conductscience.org/library/papers/28860505PubMed
1929776929Antibacterial Effects of Phage Lysin LysGH15 on Planktonic Cells and Biofilms of Diverse Staphylococci.Appl Environ Microbiol2018https://conductscience.org/library/papers/29776929PubMed
2015616283Removal of group B streptococci colonizing the vagina and oropharynx of mice with a bacteriophage lytic enzyme.Antimicrob Agents Chemother2005https://conductscience.org/library/papers/15616283PubMed

See all 168 referencesDownload CSV of references

Cited by78

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 93 citations.

PMIDTitleJournalYearIn PapersSource
42923362Global trends in phage-derived depolymerase research for anti-infective applications: a bibliometric analysis.Front Microbiol2026https://conductscience.org/library/papers/42923362PubMed
42746328Autoimmune disease-associated pathobionts: mechanisms and therapeutic potential of phage-based approaches.Front Immunol2026https://conductscience.org/library/papers/42746328PubMed
42726361A dual-functional dendrimer-based system integrating recombinant endolysin and cinnamic acid for enhanced endolysin stability and antibacterial activity against Acinetobacter baumannii.World J Microbiol Biotechnol2026https://conductscience.org/library/papers/42726361PubMed
42564788Domain shuffling of endolysin LysKB317 to control Limosilactobacillus fermentum in corn mash fermentation.Biotechnol Rep (Amst)2026https://conductscience.org/library/papers/42564788PubMed
42539602Bacteriophage lysins: a promising strategy for combating foodborne pathogens in food safety.Front Microbiol2026https://conductscience.org/library/papers/42539602PubMed
42505660Phage-Derived Endolysins Targeting Cutibacterium acnes: A Scoping Review.Antibiotics (Basel)2026https://conductscience.org/library/papers/42505660PubMed
42467470Data mining reveals the diversity of prophage endolysins targeting pathogenic enterococci.J Gen Virol2026https://conductscience.org/library/papers/42467470PubMed
42347211Prophages in Skin Pathogens: From Virulence to Therapy.Pathogens2026https://conductscience.org/library/papers/42347211PubMed
42283824Bacteriophage therapy for multidrug-resistant bacterial infections: recent advances, clinical evidence, and translational challenges.Arch Microbiol2026https://conductscience.org/library/papers/42283824PubMed
42259805Novel endopeptidase overcoming lysostaphin resistance.Sci Rep2026https://conductscience.org/library/papers/42259805PubMed
42249936First experimentally characterised Proteus phage endolysins have distinct metal cofactor dependencies.Appl Microbiol Biotechnol2026https://conductscience.org/library/papers/42249936PubMed
42207801Genomic and functional characterization of a novel halophilic bacteriophage targeting carbapenem-resistant Klebsiella pneumoniae.PLoS One2026https://conductscience.org/library/papers/42207801PubMed
42176155In silico analysis, expression, and characterization of LysStp1 endolysin with L-alanyl-D-glutamate carboxypeptidase activity.Virus Genes2026https://conductscience.org/library/papers/42176155PubMed
42119891Characterization and antibacterial efficacy of the broad-host-range phage P108 against biofilm-forming and methicillin-resistant Staphylococcus aureus.Virus Res2026https://conductscience.org/library/papers/42119891PubMed
42051596Translational barriers to phage endolysin deployment for antimicrobial resistance control in Africa.Front Antibiot2026https://conductscience.org/library/papers/42051596PubMed
42010135Search for effective bacteriolytic enzymes and their combinations for the treatment of polymicrobial biofilm-associated infections.World J Microbiol Biotechnol2026https://conductscience.org/library/papers/42010135PubMed
41675162Skin microbiome engineering: Challenges and opportunities in skin diseases treatment.IMetaOmics2025https://conductscience.org/library/papers/41675162PubMed
41648009Multidrug-resistant Pseudomonas aeruginosa infections: current status, challenges, and prospects of phage therapy.Front Microbiol2025https://conductscience.org/library/papers/41648009PubMed
41627471Phage as control strategy against the foodborne pathogen, Bacillus cereus.Arch Microbiol2026https://conductscience.org/library/papers/41627471PubMed
41600675Avian Pathogenic Escherichia coli: Advances in Pathogenesis, Diagnosis, and Control.Vet Sci2025https://conductscience.org/library/papers/41600675PubMed

See all 78 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37101261

GET https://conductscience.org/api/papers/v1/37101261/references?page=2